Related Experiment Video
Updated: Mar 7, 2026
08:10
Multi-enzyme Screening Using a High-throughput Genetic Enzyme Screening System
Published on: August 8, 2016
9.3K
GPR55: a new promising target for metabolism?
Eva Tudurí1,2, Monica Imbernon1,2,3, Rene Javier Hernández-Bautista1,2,3
1Instituto de Investigaciones Sanitarias (IDIS)CIMUS, University of Santiago de Compostela, Santiago de Compostela, Spain.
Journal of Molecular Endocrinology
|February 16, 2017
Summary
G protein-coupled receptor 55 (GPR55), a potential cannabinoid receptor, regulates energy balance and glucose metabolism. Research explores its role in feeding, nutrient partitioning, and insulin secretion for potential obesity and type 2 diabetes treatments.
Area of Science:
- Endocrinology
- Metabolism
- Pharmacology
Background:
- G protein-coupled receptor 55 (GPR55) is recognized as a novel cannabinoid receptor.
- Its widespread distribution in the brain and peripheral tissues suggests a role in diverse biological functions.
- Lysophosphatidylinositol (LPI) is the established endogenous ligand for GPR55.
Purpose of the Study:
- To review the function of GPR55 in regulating energy balance.
- To examine the role of GPR55 in glucose metabolism.
- To discuss the therapeutic potential and challenges of targeting GPR55 for metabolic diseases.
Main Methods:
- Review of preclinical studies on GPR55's effects on feeding behavior.
- Analysis of GPR55's impact on nutrient partitioning and gastrointestinal motility in animal models.
- Evaluation of available human data regarding GPR55 and insulin secretion.
Main Results:
- GPR55 influences feeding behavior and nutrient distribution.
- The receptor affects gastrointestinal motility and insulin secretion.
- Preclinical data indicate a significant role in metabolic regulation, with limited human data.
Conclusions:
- GPR55 plays a crucial role in modulating energy homeostasis and glucose metabolism.
- Targeting GPR55 presents a potential therapeutic strategy for obesity and type 2 diabetes.
- Further research is needed to overcome challenges and validate GPR55 as a drug target.
Related Concept Videos
01:15G Protein-coupled Receptors
18.6K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
18.6K
01:19Regulation of Metabolism
12.0K
Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
12.0K
01:27Transducer Mechanism: Enzyme-Linked Receptors
4.6K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
4.6K
01:29Pharmacogenomics: Identification of New Drug Targets
56
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
56
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
60
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
60
01:27Pharmacogenetics of Drug Metabolism: Overview
77
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
77